WebJan 7, 2024 · Especially for MD- and MT-IPMN, a high index of suspicion is warranted due to higher risk of malignant transformation compared to BD-IPMN. For most patients with BD-IPMN, surveillance programs with periodic MRI every 6 to 24 months are recommended, with the interval of surveillance depending on the size of the largest cyst [ 3, 7, 8 ]. WebNov 16, 2016 · High-risk features: MPD dilatation ≥ 1 cm, enhancing solid mural nodularity, or biliary obstruction (Left) Graphic shows combined main and side branch IPMN with gross dilatation of all ducts by mucin, which …
"High-risk stigmata" of the 2012 international consensus ... - PubMed
WebJul 21, 2024 · Little is known about the development of branch duct intraductal papillary mucinous neoplasms (BD-IPMNs). We evaluated long-term outcomes of a large cohort of patients with BD-IPMNs to determine risk of malignancy and define a subset of low-risk BD-IPMNs. ... suggesting the capture of cysts with more high-risk features, only 27% (85 of … WebFeb 5, 2024 · The different diagnostic threshold of PTC nuclear features resulted in a high (50–90%) incidence of BRAFV600E mutation of PTCs in most Asian countries, whereas it was low (35–50%) in most Western patient cohorts. ... the author of this commentary assumes that most were not high-risk invasive encapsulated follicular variant PTCs but … darrin smith-duber rate my
Rapid Growth Rates of Suspected Pancreatic Cyst Branch Duct
WebApr 30, 2015 · Two hundred and eighty-four patients with suspected BD-IPMN without worrisome features or high-risk stigmata were followed for a median 56 months and underwent a median of four imaging studies. Nine patients (3.2 %) developed malignant BD-IPMN. Malignant BD-IPMN grew at a faster rate (18.6 vs. 0.8 mm/year; P = 0.05) … WebFeb 3, 2024 · branch duct IPMN main pancreatic duct over 5 mm cyst diameter ≥3 cm presence of a contrast-enhancing mural nodule ≥5 mm 16 presence of solid mass 16 … WebNov 4, 2024 · The core strategy for the management of MCNs and IPMNs is surgical resection of tumors with imaging high-risk features [14, 15]. However, few literatures focused on the differences in postoperative clinicopathologic features, recurrence rate, survival rate, and recurrence factors between MCNs and IPMNs. darrin swackhamer